Phase I Study to Evaluate Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.
Phase of Trial: Phase I
Latest Information Update: 08 Aug 2017
At a glance
- Drugs Fosfomycin tromethamine (Primary)
- Indications Urinary tract infections
- Focus Adverse reactions; Pharmacokinetics
- Acronyms PROOF
- 28 Nov 2016 Status changed from active, no longer recruiting to completed.
- 22 Aug 2016 Planned End Date changed from 1 Oct 2016 to 1 Nov 2016.
- 22 Aug 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Oct 2016.